29
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Mechanism of Qiguiyin Decoction Sensitizing Levofloxacin Against Multidrug-Resistant Pseudomonas aeruginosa Infection Based on PK-PD and Antibody Chip Technology

, , , , , , & show all
Pages 2089-2098 | Received 16 Dec 2023, Accepted 18 Apr 2024, Published online: 27 May 2024

References

  • Zhao L, Wang S, Li X, He X, Jian L. Development of in vitro resistance to fluoroquinolones in Pseudomonas aeruginosa. Antimicrob Resist Infect Control. 2020;9(1):124. doi:10.1186/s13756-020-00793-8
  • Kirikae T. Multidrug-resistant Pseudomonas aeruginosa T. Nihon Rinsho Japan J Clin Med. 2012;70(2):231–235.
  • Liu ZH, Xu Y, Duo LB, et al. Pseudomonas aeruginosa isolates of distinct sub-genotypes exhibit similar potential of antimicrobial resistance by drugs exposure. Antonie van Leeuwenhoek. 2013;103(4):797–807. doi:10.1007/s10482-012-9862-4
  • Swathirajan CR, Rameshkumar MR, Solomon SS, Vignesh R, Balakrishnan P. Changing drug resistance profile in Pseudomonas aeruginosa infection among HIV patients from 2010-2017: a retrospective study. J Global Antimicrob Resist. 2019;16:274–277. doi:10.1016/j.jgar.2018.10.019
  • Guo Y, Ban W, Yang L, Shi G. Analysis of drug resistance characteristics of pulmonary tuberculosis complicated with Pseudomonas aeruginosa infection. Chin Med J. 2022;57(07):801–803.
  • Pang Z, Zhu Q. Traditional Chinese Medicine is an Alternative Therapeutic Option for Treatment of Pseudomonas aeruginosa Infections. Front Pharmacol. 2021;12:737252. doi:10.3389/fphar.2021.737252
  • Cai Y, Zhang Q, Fu Y, et al. Effectiveness of Chinese Herbal Medicine Combined with antibiotics for extensively drug-resistant enterobacteria and nonfermentative bacteria infection: real-life experience in a retrospective cohort. Biomed Res Int. 2017;2017:2897045. doi:10.1155/2017/2897045
  • Hou Y, Nie Y, Cheng B, et al. Qingfei Xiaoyan Wan, a traditional Chinese medicine formula, ameliorates Pseudomonas aeruginosa-induced acute lung inflammation by regulation of PI3K/AKT and Ras/MAPK pathways. Acta Pharmaceutica Sinica B. 2016;6(3):212–221. doi:10.1016/j.apsb.2016.03.002
  • Yu M, Gu X, Qu Y, et al. Combination therapy with TCM preparation kumu injection and azithromycin against bacterial infection and inflammation: in vitro and in vivo. Evid Based Complement Alternat Med. 2022;2022:8533005. doi:10.1155/2022/8533005
  • Huang P, Guo Y, Zhao J, Li B, Wu Y, Liu Q. Efficacy and safety of the Qiguiyin formula in severe pneumonia: study protocol for a randomized, double-blind, placebo-controlled clinical trial. J Traditional Chin Med. 2020;40(2):317–323.
  • Kong LB, Ma Q, Gao J, et al. Effect of Qiguiyin Decoction on multidrug-resistant Pseudomonas aeruginosa infection in rats. Chin J Integr Med. 2015;21(12):916–921. doi:10.1007/s11655-015-2089-2
  • Chen G, Zhang W, Kong L, et al. Qiguiyin decoction improves multidrug-resistant Pseudomonas aeruginosa infection in rats by regulating inflammatory cytokines and the TLR4/MyD88/NF-κB signaling pathway. Biomed Res Int. 2022;2022:5066434. doi:10.1155/2022/5066434
  • Naik P, Singh S, Vishwakarma S, et al. Multidrug-resistant Pseudomonas aeruginosa evokes differential inflammatory responses in human microglial and retinal pigment epithelial cells. Microorg. 2020;8(5):735. doi:10.3390/microorganisms8050735
  • Miyoshi-Akiyama T, Tada T, Ohmagari N, et al. Emergence and spread of epidemic multidrug-resistant Pseudomonas aeruginosa. Genome Biol Evol. 2017;9(12):3238–3245. doi:10.1093/gbe/evx243
  • Fish DN, Chow AT. The clinical pharmacokinetics of levofloxacin. Clin Pharmacokinet. 1997;32(2):101–119. doi:10.2165/00003088-199732020-00002
  • Chulavatnatol S, Chindavijak B, Vibhagool A, Wananukul W, Sriapha C, Sirisangtragul C. Pharmacokinetics of levofloxacin in healthy Thai male volunteers. J Med Assoc Thailand. 1999;82(11):1127–1135.
  • Choi JS, Choi I, Choi DH. Effects of nifedipine on the pharmacokinetics of repaglinide in rats: possible role of CYP3A4 and P-glycoprotein inhibition by nifedipine. Pharmacol Rep. 2013;65(5):1422–1430. doi:10.1016/S1734-1140(13)71502-0
  • Goud T, Maddi S, Nayakanti D, Thatipamula RP. Altered pharmacokinetics and pharmacodynamics of repaglinide by ritonavir in rats with healthy, diabetic and impaired hepatic function. Drug Metabol Person Ther. 2016;31(2):123–130. doi:10.1515/dmpt-2015-0046
  • Kong L, Liu Q, Yang Q, Gao J, Fu Y. Effect of Qiguiyin Prescription on in vitro inhibition of multidrug-resistant Pseudomonas aeruginosa by antibiotics. World J Tradit Chin Med. 2014;9(03):288–290+295.
  • Ding J, Ding X, Lu Y, An S, Cui X, Liu Q. Preliminary study on immunomodulatory effect of Qi Guiyin on pneumonia induced by Pseudomonas aeruginosa in rats. J Hebei Tradit Chin Med Pharmacol. 2019;34(02):1–5.
  • Liang L, Jin X, Li J, et al. A comprehensive review of pharmacokinetics and pharmacodynamics in animals: exploration of interaction with antibiotics of shuang-huang- lian preparations. Curr Top Med Chem. 2022;22(2):83–94. doi:10.2174/1568026621666211012111442